X

Trial Profile

A Study of the Effects of JNJ 26489112 on the Photic Induced Paroxysmal Electroencephalogram Response in Patients With Photosensitive Epilepsy.

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 31 Mar 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs JNJ 26489112 (Primary)
Indications Epilepsy
Focus Pharmacodynamics

Most Recent Events

31 Aug 2013 Results presented at the 11th Congress of the European Association for Clinical Pharmacology and Therapeutics
04 Jul 2012 Janssen-Cilag added as associations as reported in the European Clinical Trials Database record.
27 Aug 2009 Status changed from suspended to completed as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com